SPC144
Pembrólísúmab
Status:
VeittApplication date:
18.12.2015Application published:
15.1.2016Grant published:
15.10.2019
Max expiry date:
20.1.2031Medicine name:
KeytrudaMedicine for children:
Yes
Timeline
Today
18.12.2015Application
15.1.2016Publication
15.10.2019Registration
20.1.2031Expires
Marketing license
IS authorization number:
EU/1/15/1024/001Date:
13.8.2015
Foreign authorization number:
EU/1/15/1024Date:
21.7.2015
Owner
Name:
Merck Sharp & Dohme B.V.Address:
Waarderweg 39, BN Haarlem NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2170959